Alnylam Pharmaceuticals, Inc. (ALNY)
390.76
-0.74
(-0.19%)
USD |
NASDAQ |
Dec 16, 12:52
Alnylam Pharmaceuticals Research and Development Expense (Annual): 1.126B for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Pfizer Inc. | 10.74B |
| Bristol Myers Squibb Co. | 9.782B |
| BridgeBio Pharma, Inc. | 506.46M |
| Amgen, Inc. | 5.676B |
| Vertex Pharmaceuticals, Inc. | 3.630B |